Cargando…

Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries

OBJECTIVE: Soluble CD163 (sCD163) has been previously shown to play a role in inflammatory and infectious diseases. This study, for the first time, investigates the characteristics and potential values of sCD163 in burn patients. A first look is taken on the changes of sCD163 levels in burn patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piatkowski, Andrzej, Grieb, Gerrit, Das, Rittuparna, Bozkurt, Ahmet, Ulrich, Dietmar, Pallua, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publication 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111102/ https://www.ncbi.nlm.nih.gov/pubmed/21713197 http://dx.doi.org/10.4103/0970-0358.81454

Ejemplares similares

Treatment of burns in the first 24 hours: simple and practical guide by answering 10 questions in a step-by-step form
por: Alharbi, Ziyad, et al.
Publicado: (2012)

Calciphylaxis – a challenging & solvable task for plastic surgery? A case report
por: Tsolakidis, Savas, et al.
Publicado: (2013)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Anterior interosseous nerve syndrome: retrospective analysis of 14 patients
por: Ulrich, Dietmar, et al.
Publicado: (2011)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

Soluble CD 163: A novel biomarker
por: Ahuja, Rajeev B.
Publicado: (2011)

Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
por: Frantz, Camelia, et al.
Publicado: (2018)

Soluble CD163 in intracerebral hemorrhage: biomarker for perihematomal edema
por: Roy‐O'Reilly, Meaghan, et al.
Publicado: (2017)

Local production of soluble CD163 in the spondyloarthropathic joint
por: Baeten, D, et al.
Publicado: (2003)

Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss
por: Xie, Peilin, et al.
Publicado: (2022)

Macrophage Migration Inhibitory Factor—An Innovative Indicator for Free Flap Ischemia after Microsurgical Reconstruction
por: Megas, Ioannis-Fivos, et al.
Publicado: (2021)

Infections in Burn Patients: A Retrospective View over Seven Years
por: Tsolakidis, Savas, et al.
Publicado: (2022)

Soluble CD163-Associated Dietary Patterns and the Risk of Metabolic Syndrome
por: Hu, Tzu-Yu, et al.
Publicado: (2019)

Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease
por: Azuma, Yoshihiro, et al.
Publicado: (2020)

Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis
por: Zhang, Yue, et al.
Publicado: (2021)

A Rare Case of Toxic Epidermal Necrolysis with Unexpected Fever Resulting from Dengue Virus
por: Grieb, Gerrit, et al.
Publicado: (2010)

Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022)

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021)

Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis
por: Sherman, Kenneth E, et al.
Publicado: (2021)

Corrigendum: Urine soluble CD163 is a promising biomarker for the diagnosis and evaluation of lupus nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022)

Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2
por: Mostafa, Gehan Ahmed, et al.
Publicado: (2022)

Soluble haemoglobin scavenger receptor (sCD163): a marker associated with bacteraemia
por: Gaïni, S, et al.
Publicado: (2005)

Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance
por: Dereke, Jonatan, et al.
Publicado: (2019)

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2021)

Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status
por: Gong, Shaomin, et al.
Publicado: (2021)

Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
por: Nissen, Sara Konstantin, et al.
Publicado: (2020)

Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis
por: Kawanaka, Miwa, et al.
Publicado: (2023)

The Leukocyte VCS Parameters Compared with Procalcitonin, Interleukin-6, and Soluble Hemoglobin Scavenger Receptor sCD163 for Prediction of Sepsis in Patients with Cirrhosis
por: Guo, Fan, et al.
Publicado: (2019)

Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment
por: Simons, David, et al.
Publicado: (2011)

Urinary soluble CD163 as a biomarker of disease activity and relapse in antineutrophil cytoplasm antibody-associated glomerulonephritis
por: Villacorta, Javier, et al.
Publicado: (2020)

Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
por: Stilund, Morten, et al.
Publicado: (2014)

Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
por: Mueller, Jessica L, et al.
Publicado: (2015)

Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease
por: Enomoto, Yasunori, et al.
Publicado: (2017)

Soluble CD163 was linked to galectin-3, diabetic retinopathy and antidepressants in type 1 diabetes
por: Melin, Eva O, et al.
Publicado: (2018)

Circulating Soluble CD163: A Potential Predictor for the Functional Outcome of Acute Ischemic Stroke
por: Sun, Houchao, et al.
Publicado: (2021)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
por: Farag, Azza Gaber Antar, et al.
Publicado: (2020)

Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients
por: Kjærgaard, Anders G., et al.
Publicado: (2014)

Reconstructive surgery in immunocompromised patients: evaluation and therapy
por: Dunda, Sebastian E., et al.
Publicado: (2015)

Soluble ST2 and CD163 as Potential Biomarkers to Differentiate Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
por: Gao, Zhuo, et al.
Publicado: (2019)

CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood
por: Krijgsman, Daniëlle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r7fj9iuur9urni6jsl9eu8mf2n